Search General Info
Search Education
Search Partnering Companies

Phyllis Arthur, MBA

Washington, District Of Columbia, United States
In her role at BIO, Ms. Arthur is responsible for working with member companies in vaccines, molecular diagnostics and bio-defense on policy, legislative and regulatory issues. Ms. Arthur joined BIO in July 2009 as the Director of Healthcare Regulatory Affairs. Prior to joining BIO, she worked in numerous marketing and sales positions for Merck & Co., Inc. in their Vaccine Division. Over her 16 year career in vaccines Ms. Arthur launched several exciting new vaccines in the United States and internationally, including the first HPV vaccine GARDASIL. During her years in Marketing she worked closely with clinical and academic thought leaders in infectious diseases, oncology and public health. In addition, Ms. Arthur also led a large vaccine sales organization of over 75 representatives and managers covering 14 states. Before graduate school, Ms. Arthur worked as a research assistant for two economists at the Brookings Institution in Washington, DC. There she conducted economic analyses related to savings and investment policies for the OECD countries. Ms. Arthur received her B.A. in 1987 in Economics and International Politics from Goucher College and her MBA in 1991 from the Wharton School of Business at the University of Pennsylvania.
Speaking In
10:30 AM - 11:45 AM (PDT)
Monday, June 8
As the consequences of COVID-19 infection have been felt around the world, companies moved swiftly…
11:00 AM - 1:30 PM (PDT)
Tuesday, June 9
The long-term solution to the pandemic is the availability of vaccines. Yet the development of a…
10:00 AM - 10:55 AM (PDT)
Wednesday, June 10
The race to develop a safe and efficacious novel coronavirus vaccine and COVID-19 therapeutic is on…
[Available On-Demand]
How do we stop the spread of the novel coronavirus and safely treat those with COVID-19 if we don’t…